Senior Director, Team Lead, KAT6i (Prifetrastat), US Breast Cancer

Pfizer•New York City, NY
•$214,900 - $358,100•Hybrid

About The Position

Pfizer is seeking a Senior Director, Team Lead to build the US commercial foundation for prifetrastat (PF-07248144), a first-in-class KAT6 inhibitor in Phase 3 for HR+/HER2- advanced breast cancer following prior CDK4/6 inhibitor therapy. The role owns US launch preparation, connects the strategy to Pfizer’s broader breast cancer franchise, and leads a team of up to 3–4 marketers at Director and Senior Manager levels, including a dedicated launch lead. The position reports to the VP, US Breast Cancer Franchise Lead. The leader will develop the launch strategy and pre-launch P&L, prepare the market and customers, shape access and patient-support plans, and coordinate launch readiness across commercial and cross-functional teams. The work includes addressing the fragmented post-CDK4/6 treatment landscape, biomarker-testing readiness, tolerability and dose management, and customer value. The role also maps the patient journey across first-line and post-CDK4/6 treatment, aligns field plans with Sales and KAD leadership, and uses customer insights, analytics, and innovative approaches—including AI—to evolve the go-to-market model. This is a hybrid position based in New York, NY, or Collegeville, PA, with 2–3 days per week onsite and domestic travel of up to 25% as needed. The role may also require international travel for congresses, sales meetings, and customer interactions. The listed annual base salary range is $214,900–$358,100, with eligibility for a performance bonus and a share-based long-term incentive program.

Requirements

  • Bachelor’s degree and 12+ years of pharmaceutical industry experience, or a master’s degree and 10+ years of pharmaceutical industry experience.
  • US marketing experience focused on HCP stakeholders, including pre-launch or launch work.
  • Deep understanding of US market dynamics, including specialty channels, organized customers, and payers.
  • Demonstrated success developing, executing, and measuring complex marketing programs and championing innovative solutions.
  • At least 5 years of direct or matrix management or coaching of marketing colleagues from Manager to Director levels.
  • Demonstrated ability to identify customer needs and translate insights into meaningful strategies and tactics.
  • Collaborative leadership skills, including the ability to influence peers, engage cross-functional experts, develop and coach others, and guide colleagues’ work.
  • Demonstrated use of AI and advanced analytics to improve customer insight, targeting, forecasting, and investment decisions.
  • Strong analytical skills; attention to detail; action orientation; creativity; flexibility; and self-motivation.
  • Excellent verbal and written communication skills for a wide range of audiences.
  • Ability to synthesize and analyze complex data, understand trends, and perform mathematical calculations.
  • Ability to work on a computer for extended periods using common applications such as Outlook, Excel, and PowerPoint.
  • Ability to travel domestically and internationally as needed; domestic travel may be up to 25%.
  • Permanent work authorization in the United States.

Nice To Haves

  • Oncology or breast cancer marketing experience.
  • Experience leading patient marketing, including DTC/DTP strategy, patient support and adherence programs, and advocacy engagement, with integration of patient and HCP strategies.
  • Experience leading a US oncology or specialty product launch from pre-launch market shaping through commercialization.
  • Experience with biomarker-driven or precision-medicine launches, including diagnostic-testing readiness.
  • Experience designing, piloting, or scaling new go-to-market models, such as omnichannel or AI-enabled engagement, hybrid field/digital coverage, or account-based approaches.
  • Comfort working in a fast-paced environment and making complex decisions quickly.

Responsibilities

  • Own the prifetrastat pre-launch P&L and launch budget, including the long-range forecast, investment case, operating expenses, and resource allocation.
  • Lead US commercial strategy, including target product profile input, positioning, segmentation, target customers, and HCP and account launch plans.
  • Assess the market landscape, including circulating tumor DNA (CtDNA) and competitive entrants in the post-CDK4/6 treatment paradigm.
  • Shape the market ahead of approval through disease-state education and pre-launch engagement with customers and advocacy groups, partnering with Medical Affairs and Patient Advocacy.
  • Develop launch workstreams addressing differentiation, biomarker-testing readiness, tolerability and dose-management support, and customer value.
  • Define launch-readiness milestones, evidence needs, and the investment case with Clinical Development, Market Access, Commercial Insights, and Sales.
  • Partner with Market Access, Pricing, and Trade on pricing and contracting, channel and distribution, and gross-to-net strategy.
  • Build the patient and advocacy strategy, including DTC/DTP, patient support, and adherence programs, with tolerability and dose management considered for HCPs and patients.
  • Map the patient journey from first-line CDK4/6 inhibitor use to post-CDK4/6 treatment and align IBRANCE, atirmociclib, and prifetrastat strategies.
  • Align with Breast Cancer Sales and KAD leadership on incorporating prifetrastat into annual POAs and field focus, using customer-facing colleague feedback as the portfolio changes.
  • Lead the customer insight plan with analytics, customer-facing colleagues, and cross-functional partners; use insights to adapt strategy and anticipate HCP treatment sequencing after CDK4/6 progression.
  • Develop innovative approaches where no established playbook exists, particularly for AI and the go-to-market model.
  • Manage, engage, and coach the team; support performance and development; and plan roles and succession as the team scales toward launch.
  • Foster a positive team culture and collaboration across the broader US Breast Cancer marketing team.
  • Participate in leadership presentations, performance updates, and operating expense management to support Pfizer’s Breast Cancer business.

Benefits

  • 401(k) plan with Pfizer matching contributions and an additional Pfizer Retirement Savings Contribution.
  • Paid vacation, holidays, and personal days.
  • Paid caregiver, parental, and medical leave.
  • Medical, prescription drug, dental, and vision coverage.
  • Eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 22.5% of base salary.
  • Eligible to participate in Pfizer’s share-based long-term incentive program.
  • Relocation assistance may be available based on business needs and/or eligibility.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service